Target intelligence / Profile preview

CD82 antisense RNA 1 (CD82-AS1)

Target: CD82-AS1
Molecular classification: Long non-coding RNA, Other

Overview

CD82 antisense RNA 1 (CD82-AS1) is a long non-coding RNA transcribed antisense to the CD82 gene. CD82-AS1 does not code for a protein, and its functional role has not been established in detail. Unlike the protein-coding gene CD82, which is known for its role as a metastasis suppressor and involvement in cancer biology[4][5][7][10], CD82-AS1 is primarily annotated as an RNA gene with currently limited evidence for direct involvement in specific biological processes or diseases. No drugs are known to target this RNA, and it is not classified as a receptor, enzyme, or other classical drug target. Its aliases include "CD82 antisense RNA 1" and "CD82-AS1"[1].

Other names: CD82 antisense RNA 1CD82-AS1

Mechanism of action

Null

Beyond the preview

Go deeper on CD82 antisense RNA 1 (CD82-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD82 antisense RNA 1 (CD82-AS1).

Explore the full profile